Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TatD DNase domain containing 2 pseudogene 1 (TATDN2P1) is a pseudogene related to the TatD DNase enzyme family. Pseudogenes are segments of DNA resembling protein-coding genes but are traditionally considered non-functional due to mutations or loss of regulatory elements. Recent proteogenomic analyses indicate that some pseudogenes, including TATDN2P1, may be sporadically transcribed and even translated in a tissue-specific manner—TATDN2P1 was detected via mass spectrometry as a putative protein expressed specifically in human testis[1]. However, the biological and functional significance of TATDN2P1-encoded peptides remains unclear. Like other pseudogenes, TATDN2P1 may also regulate its parental gene (TATDN2) or broader cellular processes via non-coding RNA mechanisms, such as serving as competitive endogenous RNAs that sponge microRNAs, although there is no direct experimental evidence for this specific gene[2][3]. There are no current data establishing TATDN2P1 as a therapeutic target, biomarker, or safety concern. Key points: - **TATDN2P1 is a pseudogene** and not a traditional protein-coding gene or receptor/enzyme/drug target[5][3]. - No known **drugs interact with this gene**, and there is no evidence it functions as a receptor or enzyme in therapeutic contexts. - Some limited proteomic data suggest **possible protein production in testis**, but the functional significance is unknown[1]. - As is typical for pseudogenes, it is not considered a **therapeutic target**. - It may require **manual curation in databases**; entries related to TATDN2P1 should be carefully verified for functional relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TatD DNase domain containing 2 pseudogene 1 (TATDN2P1).